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Summary 
Shigella sonnei is a bacterial pathogen and causative agent of bacillary dysentery. It deploys a 
type III secretion system to inject effector proteins into host epithelial cells and macrophages, 
an essential step for tissue invasion and immune evasion. Although the arsenal of bacterial 
effectors and their cellular targets have been studied extensively, little is known about the 
prerequisites for deployment of type III secreted proteins during infection. Here, we describe 
a novel S. sonnei adhesin, SSO1327 which is a multivalent adhesion molecule (MAM) 
required for invasion of epithelial cells and macrophages and for infection in vivo. 
The S. sonnei MAM mediates intimate attachment to host cells, which is required for efficient 
translocation of type III effectors into host cells. SSO1327 is non‐redundant to IcsA; its 
activity is independent of type III secretion. In contrast to the up‐regulation of IcsA‐
dependent and independent attachment and invasion by deoxycholate in Shigella flexneri, 
deoxycholate negatively regulates IcsA and MAM in S. sonnei resulting in reduction in 
attachment and invasion and virulence attenuation in vivo. A strain deficient for SSO1327 is 
avirulent in vivo, but still elicits a host immune response. 
Introduction 
Bacillary dysentery remains a significant threat to public health in the 21st century, with an 
estimated 160 million episodes worldwide per annum and 1.1 million deaths, of which most 
are children under 5 years old (Kotloff et al., 1999). More recent studies show that Shigella 
sonnei has indeed become the most prevalent agent in newly industrialized countries such as 
Korea, Republic of China, Thailand and Iran, and is more associated with dysentery in infants 
(Seol et al., 2006; Ranjbar et al., 2007). S. sonnei originated in Europe and recently 
disseminated globally. Fast‐evolving and multidrug‐resistant clones of S. sonnei are 
responsible for the current dysentery pandemic (Holt et al., 2012). 
Shigella  infection is transmitted through contaminated food or water (Chen et al., 2001; 
Leclerc et al., 2002). Shigella  is highly invasive with very low infectious doses (10–100 
CFU) (DuPont et al., 1989). Invasion occurs in the recto‐colonic mucosa via M cells. 
Equipped with a type III secretion system (TTSS), the bacteria then invade resident 
macrophages as well as epithelial cells via the basolateral side. The TTSS injects the effector 
IpaB into macrophages, which activates caspase I (also known as interleukin I converting 
enzyme) and in turn triggers apoptosis to kill macrophages. Caspase I activation also results 
in release of activated interleukin (IL)‐Iβ and IL‐18, which initiates a pro‐inflammatory 
response (Thirumalai et al., 1997). Upon contact with epithelial cells, the TTSS translocates a 
first wave of effector proteins, which cause actin rearrangements and facilitate bacterial 
invasion, vacuolar escape and covert intracellular replication. The intracellular bacteria then 
translocate via TTSS a second wave of effectors that hijack host signalling, inhibit apotosis 
and manipulate host innate and adaptive immunity (Schroeder and Hilbi, 2008). Via a surface 
protein, IcsA, the bacteria polymerize host actin that enables bacteria spread intra‐ and inter‐
cellularly (Bernardini et al., 1989). The lateral spread of the bacteria from cell‐to‐cell results 
in the infection and killing of neighboring epithelial cells, causing ulcers, bleeding and 
mucosal inflammation (Niyogi, 2005). While initial extracellular translocation of effectors is 
necessary to trigger invasion, intracellular growth, persistence and spread are required for 
virulence in vivo; all these events are mediated by TTSS (Schroeder and Hilbi, 2008). 
Shigella  originated from multiple lineages of Escherichia coli, and has evolved mainly 
through genome reduction through the action of translocation, inversion and frame shifts 
mediated by insertion sequences and transposons (Yang et al., 2005). Many genes encoding 
pili and fimbriae required for host attachment are inactivated in Shigella , and it has long been 
assumed that the organisms’ capability to invade in a TTSS‐dependent fashion has eliminated 
the need for adhesion (Yang et al., 2005). More recently, it has been demonstrated that 
the Shigella flexneri protein IcsA plays a dual role in actin‐based motility and adhesion and 
its role as an adhesin, which is also TTSS‐dependent, is required for pathogenesis (Brotcke 
Zumsteg et al., 2014). 
We are studying the molecular pathogenesis of S. sonnei, and found the sequenced S. sonnei 
strain Ss046 contains an intact gene encoding for a putative multivalent adhesion molecule 
(MAM) (SS01327), a protein of 879 amino acids with seven mammalian cell entry (MCE) 
domains (Fig. S1A). MAMs are widely distributed proteins in Gram‐negative bacteria. The 
best characterized ortholog, MAM7 from the food‐borne pathogen Vibrio parahaemolyticus, 
consists of an N‐terminal hydrophobic region, which is required for outer membrane 
targeting and anchoring of the protein. This region is followed by a stretch of six to seven 
MCE domains which are responsible for host cell binding. MCE domains mediate binding to 
fibronectin and phosphatidic acid on the host cell membrane (Krachler and Orth, 2011; 
Krachler et al., 2011). MAM‐mediated binding has been demonstrated to be important for 
pathogenicity in a numbers of pathogens, including Yersinia pseudotuberculosis, Vibrio 
cholerae, V. parahaemolyticus and enteropathogenic E. coli (Krachler and Orth, 2011; 
Krachler et al., 2011; Lim et al., 2014). Prevention of MAM‐mediated binding has thus 
offered a new strategy in treatment of various bacterial infections (Krachler et al., 2012b; 
Hawley et al., 2013; Krachler and Orth, 2013). 
In addition to S. sonnei SS01327, intact MAM orthologs are also present in Shigella 
dysenteriaeand Shigella boydii. While function of the only described Shigella  adhesin 
identified to date, IcsA, strictly depends on TTSS activity, MAMs are constitutively active 
and thus are able to establish contact between host and pathogen during the earliest stages of 
infection (Krachler and Orth, 2011; Krachler et al., 2011). This has intrigued us to investigate 
whether the MAM ortholog in S. sonnei is functional and required for virulence. Here we 
present evidence that MAM‐mediated adherence is non‐redundant with IcsA‐mediated 
attachment. It is a prerequisite for TTSS‐mediated invasion of host epithelial and phagocytic 
cells and necessary for Shigella  pathogenicity in vivo. 
 
Results 
MAM is widely conserved across Shigella species 
Using the sequence of the well‐characterized MAM VP1611 from V. parahaemolyticus, we 
performed a search for MAM orthologs in Shigella . This revealed that S. sonnei Ss046 
harbors an intact MAM ortholog, SSO1327, a putative protein of 879 amino acids sharing 
35% identity and 25% similarity with V. parahaemolyticus VP1611. Its topology and domain 
organization was predicted to be highly similar to that of VP1611, containing an N‐terminal 
hydrophobic stretch of 41 residues and seven putative tandem MCE domains (Fig. S1A). 
SSO1327 is encoded on the chromosome nearby an ipaH pathogenicity island that 
carries ipaH_3, encoding a type III secreted effector (Fig. S1B). MAM orthologs were also 
identified in several other Shigella  species, including S. boydii (SB01249) 
and S. dysenteriae (SDY1λ85), within a similar genetic context (Fig. S1B). In contrast, 
the S. flexneri MAM ortholog, SF1391, is a pseudogene, encoding for a truncated protein 
(Fig. S1B). To further investigate the potential biological function of the S. sonnei MAM 
SSO1327, we constructed a non‐polar deletion strain in wild‐type S. sonnei strain 20071599 
(Xu et al., 2014), ΔSSO1327, (henceforth referred to as ΔMAM), (Fig. S1C–E). 
Shigella MAM is localized at the bacterial outer membrane and 
surface exposed 
Previous studies have shown that the V. parahaemolyticus MAM, VP1611, possesses an N‐
terminal hydrophobic region that allows protein targeting and anchoring to the outer 
membrane (Krachler and Orth, 2011; Krachler et al., 2011). We tested whether this was also 
the case for the S. sonnei MAM protein. As no MAM‐specific antibody is available, we used 
the ΔMAM strain expressing C‐terminally 6xHis‐tagged MAM (ΔMAM + pMAM‐His) to 
probe for protein localization. S. sonnei ΔMAM or ΔMAM + pMAM‐His strains were grown 
in rich media, cells subjected to subcellular fractionation and both soluble and membrane 
fractions probed for the presence of MAM using α‐His antibody. Fractionation was 
successful, as controlled for using an antibody against the outer membrane porin OmpA 
(Fig. 1A). MAM was exclusively detected in the membrane fraction of the MAM expressing 
strain, but not the deletion strain (Fig. 1A). To probe for outer membrane localization, we 
performed microscopy on enhanced green fluorescence protein (EGFP)‐expressing bacteria 
treated with α‐His antibody to detect MAM, followed by tetramethylrhodamine (TRITC)‐
labelled secondary antibody. As a control, a ΔdsbA strain was also transformed to express 
DsbA‐His, which is a periplasmic protein required for Shigella  virulence (Yu et al., 2000). 
While MAM‐His was detected both in Triton‐treated and untreated bacteria (Fig. 1Bii, and 
1Cii, respectively), DsbA‐His was only detected in Triton‐treated, but not untreated cells 
(Fig. 1Eii and 1Dii, respectively). Triton‐X100 is able to permeabilize the outer membrane, 
which renders the periplasmic DsbA‐His accessible to the antibody. As MAM‐His was 
detected in the absence of permeabilization, these data demonstrate that, like its 
orthologs, S. sonnei MAM localizes to the bacterial outer membrane, with the C‐terminus 
oriented toward the extracellular side. 
 Figure 1 
The Shigella sonnei MAM is localized at the bacterial outer membrane. 
A. S. sonnei ΔMAM (Δ) and complementation strain (ΔMAM + pMAM‐His, M) were grown to mid‐
log phase and soluble and membrane fractions separated by SDS‐PAGE. MAM and OmpA (OM 
protein, fractionation control) were detected by Western blotting using antibodies against His‐tagged 
MAM and OmpA, respectively. 
B, C, D, E. Strains ΔMAM/pMAM‐His and ΔdsbA/pDsbA‐His expressing EGFP were treated with or 
without Triton X‐100, and anti‐His antibodies, followed by TRITC‐labelled secondary antibodies. 
EGFP‐Shigella  (green), MAM‐His and DsbA‐His (red), and merged channels are shown. Scale 
bar = 5 ȝm. 
 
MAM and IcsA are two non‐redundant Shigella adhesins 
required for attachment to and invasion of host cells 
Shigella  attaches to and invades both epithelial cells and macrophages in a TTSS‐dependent 
manner. Although the contribution of TTSS structural components and effector proteins to 
these processes has been carefully evaluated in the past, until recently, nothing was known 
about factors required to initiate the intimate contact between bacteria and host cells that is 
necessary to trigger initial TTSS‐dependent translocation of effectors that facilitate invasion. 
Recently, IcsA has been described to be involved in bacteria–host association in S. flexneri. 
Thus, we tested the contribution of MAM and IcsA to S. sonnei attachment and invasion, 
both individually and in combination. 
First, we tested both S. sonnei wild‐type and deletion strains for adherence to HeLa epithelial 
cells, which are a widely used model for assessing bacterial adhesion and invasion. 
Adherence levels in the ΔMAM and the ΔicsA deletion strains dropped similarly to ∼25–20% 
compared with wild‐type levels (statistically significant, P  < 0.05). The wild‐type strain's 
attachment capacity could be restored by complementation of the deletion strains with MAM 
or IcsA, respectively, expressed in trans (Fig. 2A). A ΔMAM/ΔicsA double mutant showed 
further reduction in adherence to less than 20% compared with the wild type, indicating a 
synergistic effect between MAM and IcsA. This double mutation could be completely 
complemented to restore wild‐type levels of attachment, by expressing both MAM and IcsA 
from a single plasmid, pMI, in trans. We further tested the growth kinetics of wild‐type and 
all mutant strains (Fig. S7), and all strains grown equally well in L‐broth, ruling out growth 
defects as a reason for the different attachment and invasion phenotypes we observed. Thus, 
we conclude that IcsA and MAM contribute equally to adherence and that there is synergy 
between the two adhesins. As the double mutant still retained low levels of adherence, other, 
as yet unidentified factors may mediate adherence in the ΔMAM/ΔicsAbackground. 
 Figure 2 
Functional characterization of Shigella sonnei MAM and IcsA in host cellular adhesion and invasion. 
A. Attachment of S. sonnei strains to HeLa cells following a 15 min infection at an MOI of 30 was 
determined by Triton X‐100 lysis and plating. 
B. Invasion of HeLa cells was determined by gentamycin protection experiments following 2 h of 
infection at an MOI of 10. 
C. Conservation (Y) or absence (N) of basic residues (H/K/R) at key positions required for high 
affinity phosphatidic acid binding within MCE domains 1–7 of Vibrio 
parahaemolyticus and S. sonnei MAMs. Sequence based alignment is shown for MCE2 domains, with 
key conserved PA‐binding residues highlighted in pink. 
D. Attachment of wild‐type and complemented MAM deletion strain to HeLa cells, which were left 
untreated or treated with phospholipase C (+ PLC) or preincubated with fibronectin (+Fn). All results 
are means ± standard deviation (n = 3). Significance of results compared with those for the wild‐type 
strain was determined using a t‐test: (*) P  = 0.0163, (**) P  = 0.0021, (***) P  < 0.0001. 
 
Shigella  is well‐known for its ability to invade host cells; the significance of attachment in 
pathogenesis has only been investigated regarding IcsA's role, which is otherwise known to 
be required for actin‐based cellular motility. Therefore, we investigated whether deletion of 
the S. sonnei MAM led to reduced invasiveness, using 2 h gentamycin protection assays. 
Deletion of icsA reduced invasion to 40% of the wild‐type levels and deletion 
of MAM caused more profound reduction to less than 10% of the wild‐type levels (Fig. 2B). 
Expression of MAM or IcsA in trans, respectively, restored invasiveness in full to these two 
mutants. Removal of MAM and icsA together caused slightly more reduction than removal 
of MAMalone, indicating that MAM plays a more important role than IcsA in invasion 
(Fig. 2B). Expressing both MAM and IcsA from pMI in trans fully complemented the double 
mutant for invasion (Fig. 2B). 
In V. parahaemolyticus, attachment of the MAM VP1611 to host cells is dependent on two 
host surface receptors; direct, high‐affinity binding of MCE domains to phosphatidic acid 
membrane phospholipids via key conserved basic residues in each domain is necessary for 
adhesion, while fibronectin acts as a co‐receptor and accelerates surface engagement 
(Krachler and Orth, 2011). A comparative analysis of key basic residues reportedly involved 
in phosphatidic acid binding by VP1611, and the Shigella  MAM SSO1327 revealed a high 
level of conservation of basic residues in key lipid binding positions (Fig. 2C). Thus, we 
tested the requirement of S. sonnei MAM for phosphatidic acid and fibronectin in host cell 
adherence. Treatment of epithelial cells with phospholipase C (PLC) depletes phosphatidic 
acid from the membrane (Lim et al., 2014). Following PLC treatment, bacterial adhesion to 
host cells was decreased to ∼ 10% of wild‐type levels, and levels comparable with those 
observed for ΔMAM attachment (Fig. 2D). The requirement for fibronectin was evaluated 
using a competition assay. Pre‐incubation of bacteria with fibronectin from human plasma 
significantly decreased attachment to epithelial cells, albeit to a lower extent than 
phosphatidic acid depletion. We conclude that S. sonnei MAM has similar binding specificity 
and host receptor requirements as the V. parahaemolyticus MAM VP1611 and engages both 
phosphatidic acids and fibronectin at the host cell surface. We also noted that blocking or 
eliminating host cell receptors was more efficient in inhibiting attachment than deleting 
MAM (Fig. 2A vs. 2D). This may suggest that other, yet unidentified, adhesins also use PA 
and fibronectin for attachment. 
 
MAM is not involved in production or secretion of type III 
effectors, but enables efficient substrate translocation into host 
cells 
Shigella  invasion is dependent on a functional TTSS, and the secreted components IpaB and 
IpaC are known to form a translocon pore complex in the target cell membrane and facilitate 
the injection of effector proteins into the host cell cytoplasm to initiate invasion 
(Menard et al., 1994; Veenendaal et al., 2007). Therefore, we investigated whether removal 
of MAM reduced secretion of IpaB and IpaC, by use of Congo red as environmental cues for 
secretion in vitro as described previously (Bahrani et al., 1997). Similar levels of IpaB and 
IpaC were detected in the total cell lysates and supernatants of wild‐type, ΔMAM mutant as 
well as the complemented ΔMAM strain (Fig. 3A). Thus, removal of MAM neither affects 
TTSS protein production nor secretion. 
 
Figure 3 
Analysis of Shigella sonnei MAM role in production, secretion and translocation of type III secretion 
system substrates. 
(A) S. sonnei wild type, ΔMAM or ΔMAM/pMAM‐His strains were grown to mid‐log phase, type III 
secretion was induced with Congo red and cell lysates and culture supernatants analyzed for the 
presence of type III system secreted effectors by SDS‐PAGE and Western blotting with antibodies 
against IpaB and IpaC. HEK293 cells were either mock infected (B and G), or infected 
with S. sonnei wild‐type (C, H) or ΔMAM (D, I) strains carrying chromosomal ipgD‐bla  fusions or 
wild type carrying pGEM‐T‐Easy (E, J). Substrate translocation was analyzed by FRET imaging (B–
E). Scale bar, 10 ȝm. Results of ratiometric image analysis are means ± standard deviation (Fμ n = 3). 
Significance of results compared with those for the control (mock infection) was determined using a t‐
test and asterisks indicate P‐values < 0.001. nsμ not significant. Substrate translocation was also 
analyzed by flow cytometry (G–J). Marked increase of donor (450 nm) and decrease of acceptor 
fluorescence (535 nm) was observed in cells infected by wild‐type strain compared with cells infected 
by ΔMAM strain or cells infected by wild‐type strain carrying pGEM‐T‐Easy (H vs. I; H vs. J). 
 
Translocation of TTSS effector proteins into the host cell cytoplasm requires prolonged and 
intimate contact between bacteria and host cells. Thus, we investigated if the absence of 
MAM negatively affects the initial translocation of type III secreted effector proteins from 
adherent bacteria into host cells. HEK2λ3 cells were loaded with the β‐lactamase (Bla) 
cleavable substrate CCF4‐AM and infected with Shigella  wild‐type or ΔMAM reporter strains 
carrying a chromosomal fusion of Bla to the TTSS effector IpgD (ipgD‐bla), which is 
implicated in actin rearrangements, which facilitate bacterial invasion of non‐phagocytic cells 
upon host cell contact (Niebuhr et al., 2000). We included a negative control, wild‐type strain 
carrying p‐GEM‐T‐Easy, which expresses β‐lactamase, but will not be able to translocate it 
into host cells. Substrate translocation was analyzed by ratiometric analysis of imaged cells 
and by flow cytometry. While substrate loaded mock‐infected cells fluoresce green (Fig. 3B 
and G), wild‐type infection lead to translocation of IpgD‐Bla into the host cell cytoplasm, 
which was marked by substrate cleavage and a shift toward blue fluorescence within 50 min 
post‐infection (Fig. 3C and H). Little translocation and thus, little shift in fluorescence, was 
observed during infection with the ΔMAM reporter strain and the wild‐type strain carrying 
pGEM‐T‐Easy (Fig. 3D and I, and E and J, respectively), although all strains displayed 
similar levels of β‐lactamase activity (Fig. S2). Taken together, these experiments suggest 
that although the presence of MAM is not required for TTSS effector secretion, it is 
necessary to achieve intimate contact between bacteria and host cells required for effector 
translocation. 
MAM is required for S. sonnei pathogenesis and interaction 
with phagocytes in vivo 
Larvae of the wax moth Galleria mellonella  are an abundantly used in vivo infection model, 
including those with enteric pathogens such as enteropathogenic E. coli (EPEC) 
and Salmonella  (Leuko and Raivio, 2012; Viegas et al., 2013). It is particularly suited to 
study interactions between pathogens and phagocytic cells in a living organism 
(Harding et al., 2012). To test the function of S. sonnei MAM during pathogenesis, larvae 
were infected with doses of either 105 or 106 CFU of S. sonnei wild‐type, ΔMAM or 
complemented ΔMAM + pMAM strains by injection into the front, right proleg. Control 
animals were injected with the same volume of sterile PBS. Larvae infected with 106 CFU 
of S. sonnei wild‐type strain all succumbed to infection within one day (Fig. S4). Larvae 
infected with 105 CFU of wild‐type S. sonnei showed a pronounced phenotype with rapid 
melanization indicative of an immune response and loss of mobility, and succumbed to 
infection between days 1 and 5 following infection (Fig. 4A and E). In contrast, larvae 
infected with 105 CFU ΔMAM showed lower mortality, with 70% of animals alive on day 5 
(Fig. 4B and E). Expression of MAM in transrestored mortality rates to wild‐type levels 
(Fig. 4C and E), while all control animals lived beyond day 5 (Fig. 4D and E). 
 
 
Figure 4 
MAM is required for Shigella sonnei pathogenesis and interaction with phagocytes in vivo. 
Two‐ to 3‐day‐old G. mellonella larvae were injected with a dose of 105 CFU of S. sonnei wild type 
(A), ΔMAM (B), ΔMAM + pMAM‐His (C) or an equivalent volume of sterile buffer (D) and imaged 
on day 2. Larval mortality of animals injected with buffer (control, crosses), or 105 CFU of wild type 
(black square), ΔMAM (black triangles) or ΔMAM + pMAM‐His (empty circles) was followed over 
five days and data shown as Kaplan–Meier survival curves (E). Hemocytes were isolated from the 
hemolymph of larvae infected with S. sonnei wild type (F), mock infected (G), or infected with 
ΔMAM (H) or ΔMAM + pMAM‐His (I) at 105 CFU for 4 h. Samples were visualized by microscopy 
and DIC (grey), Hoechst (blue), GFP Shigella  (green), F‐actin (red) and merged images are shown. 
Scale bar, 5 ȝm. Bacteria per cell were quantified by image analysis (J) and at least 100 hemocytes 
were analyzed per experimental condition. NA: not analyzed. Alternatively, hemocytes (infected with 
wild‐type S. sonnei, grey or ΔMAM, green) or mock infected (yellow trace) were analyzed for GFP 
fluorescence by flow cytometry (K). All results are means ± standard deviation (n = 3). Significance of 
results compared with those for the wild‐type strain was determined using a t‐test and asterisks 
indicate P‐values < 0.0001. ns, not significant. Also see Fig. S3. 
 
Shigella sonnei virulence in the G. mellonella  larval model was strongly correlated with the 
bacteria's ability to invade phagocytes. To understand the underlying mechanisms of larval 
killing by Shigella , hemolymph was collected from larvae infected with EGFP 
expressing S. sonnei strains, and used to isolate infected phagocytes. Bacterial burden inside 
phagocytes was evaluated both by flow cytometry and fluorescence microscopy. More than 
75% of hemocytes isolated from larvae infected with wild‐type S. sonnei contained a high 
bacterial burden of approximately five bacteria per cell on average (Fig. 4F). In contrast, 
phagocytes isolated from ΔMAM infected larvae essentially lacked intracellular bacteria 
(average burden of less than one bacterium per cell) and were practically indistinguishable 
from uninfected phagocytes both by flow cytometric and microscopic analysis (Fig. 4G, H, 
K). Expression of MAM in trans restored wild‐type levels of bacterial burden and eventual 
lysis (Fig. 4I and J). G. mellonella hemocytes possess similar properties than macrophages 
from vertebrates (Harding et al., 2012). Shigella  infection typically causes macrophage 
apoptosis via the action of IpaB (Thirumalai et al., 1997). Therefore, we investigated 
whether S. sonnei causes apoptosis to G. mellonella hemocytes. Apoptotic macrophages 
typically produce fragmented chromatin, which can be detected by agarose gel 
electrophoresis (Zychlinsky et al., 1992). We isolated and analyzed total DNA 
from Shigella  infected and uninfected moth larvae. Chromatin fragmentation was apparent in 
DNA samples isolated from wild type infected, but not ΔMAM or mock‐infected larvae 
(Fig. S3). Thus, S. sonnei invaded and caused apoptosis to larvae hemocytes, mirroring the 
mechanism of killing observed in vertebrates. 
MAM‐coupled polymer beads mimic bacterial attachment and 
are protective against Shigella infection 
Previous studies showed MAM chemically coupled to polymer beads can mimic bacterial 
adhesion and competitively exclude pathogens from the host cell surface, thus attenuating 
infection (Krachler et al., 2012a). We investigated whether MAM‐coupled beads would be 
protective against S. sonnei infection in vivo, using the G. mellonella larval model. MAM‐
displaying beads were co‐injected with doses of either 105 or 106 CFU of wild‐
type S. sonneiand larvae survival monitored over time. MAM beads administered at the same 
time as S. sonnei inhibited infection (Fig. 5B) while control beads had no protective effect 
(Fig. 5C). Dosing experiments revealed that MAM beads inhibited infection with a dose of 
105 CFU to concentrations of 6 ȝM. At 106 CFU, a dose that killed all unprotected larvae 
within one day, co‐injection with MAM beads attenuated infection in a concentration‐
dependent manner (Fig. S4). An inhibitor concentration of 25 ȝM protected λ0% of larvae 
beyond day 5 post‐infection (Fig. S4). The lowest inhibitor concentration used (6 ȝM) 
protected 50% of larvae beyond day 5. The protective effect of beads was due to their ability 
to block host cell invasion in vitro and in vivo, by competitively excluding Shigella  from 
binding to the host surface receptors (Fig. 5E–I). The beads had no visible effect on 
phagocyte morphology (Fig. 5G) and did not interfere with TTSS effector production or 
secretion (Fig. S5). 
 
 
Figure 5 
A MAM mimetic adhesion inhibitor can efficiently protect against Shigella sonnei invasion and 
pathogenesis. 
Galleria mellonella larvae were injected with 105 CFU S. sonnei wild type (A), a mixture containing 
105 CFU S. sonnei and 25 ȝM MAM beads (B) or a mixture containing 105 CFU S. sonnei and 25 ȝM 
GST (control) beads (C) and imaged on day 2. Mortality rates over 5 days of larvae injected with 
105 CFU wild type and either buffer (black squares), or MAM beads at a final concentration of 25 
(empty triangles), 1λ (black triangles), 12.5 (dotted line) or 6 ȝm (empty circles) were analyzed using 
Kaplan–Meier survival curves (D). Hemocytes were isolated from larvae injected with a mixture 
containing 105 CFU S. sonnei and 25 ȝM GST (control) beads (E), a mixture containing 
105 CFU S. sonnei and 25 ȝM MAM beads (F) or 25 ȝM MAM beads but no bacteria (G). Samples 
were visualized by microscopy and DIC (grey), Hoechst (blue), GFP Shigella  (green), F‐actin (red) 
and merged images are shown. Scale bar, 5 ȝm. Bacteria per cell (green bars) and beads per cell 
(black bars) were quantified by image analysis, and at least 100 hemocytes were analyzed per 
experimental condition (H). NA: not analyzed. The effect of MAM beads or control (GST) beads on 
bacterial invasion of HEK293 cells was determined using gentamycin protection assays and compared 
with invasion of untreated (−) cells (I). Results are means ± standard deviation (n = 3). Significance of 
results was determined using a t‐test and asterisks indicate P‐values < 0.0001. nsμ not significant. Also 
see Figs–S3 and S4. 
 
MAM is required for S. sonnei induced keratoconjunctivitis and 
immunization with MAM‐deficient Shigella induces limited 
protective immunity 
Although the above data demonstrated the usefulness of G. mellonella larvae as a model 
for Shigella  infection, we also exploited the more established guinea pig keratoconjunctivitis 
model to further characterize the MAM mutant. Shigella  strains, wild‐type 
and ΔMAM mutant, as well as PBS (mock infection) were administered into the eyes (three 
animals in each group) and animals monitored for development of 
keratoconjunctivitis. S. sonnei wild‐type strain caused all three animals fully developed 
keratoconjunctivitis by day 3 (Fig. 6A and B), whereas the ΔMAM mutant did not cause any 
sign of the disease up to 14 days post‐infection in any of the animals (Fig. 6C and D). At this 
point, we tested if the attenuated ΔMAM mutant could be used as a vaccination strain. 
Therefore, we administered the same guinea pigs with ΔMAM mutant at days 14 and 28 to 
boost immunization and challenged the animals with wild‐type strain at day 33. Surprisingly, 
none of the animals showed any sign of conjunctivitis until day 36. After this, the symptoms 
progressed slowly for the worse and full keratoconjunctivitis was developed by day 41. To 
compare the immune responses elicited by the wild type and the ΔMAM mutant, we collected 
guinea pig spleens for detecting antibody secreting cells (ASC) specific 
to S. sonnei lipopolysaccharide. The ΔMAM mutant elicited similar levels of ASC than the 
wild‐type strain following ocular administration to guinea pigs (Fig. 6E). 
 
 
Figure 6 
Role of MAM in a keratoconjunctivitis model of Shigella  infection and immunity. 
(A–D) Sereny test. Guinea pigs (n = 3) were infected with 5 × 108 CFU of bacteria per eye. All 
animals infected with wild‐type S. sonnei developed full keratoconjunctivitis in 3 days. Animals 
infected with ΔMAM strain did not show any sign of conjunctivitis up to 14 days. Animals before (A) 
and after (B) infection with wild type and before (C) and after (D) infection with ΔMAM deletion 
strain for five days are shown. E. ELISPOT data. Animals in group 1 (gp/Wt) were immunized with 
ΔMAM three times and challenged with wild‐type S. sonnei; animals in group 2 (gp/delMAM) 
immunized with ΔMAM strain four times; animals in group 3 were mock infected with PBS four 
times. Both group 1 and group 2 animals produced significantly higher antibody secreting cells (ASC) 
specific to S. sonnei LPS in spleen lymphcytes compared with group 3 mock‐infected animals (** 
indicate P  < 0.001). The difference between group 1 and group 2 animals are not statistically 
significant (P  = 0.05). 
 
Deoxycholate (DOC) negatively 
regulates S. sonnei pathogenicity in vitro and in vivo 
Brotcke Zumsteg et al. (2014) have recently described positive regulation of S. flexneri by 
DOC in adherence and invasion to host cells, which are partially dependent on IcsA. We 
therefore investigated whether this is also the case for S. sonnei. First, wild‐type, ΔMAM and 
ΔicsAstrains were tested for their adherence to HeLa cells with or without DOC treatment 
(Fig. 7A). Adherence was decreased by DOC in wild‐type and all single‐deletion strains. 
DOC equally decreased invasion of HeLa cells by wild‐type and all mutant strains (Fig. 7B). 
Next, transcription levels of MAM and icsA in the presence and absence of DOC treatment 
were compared using quantitative polymerase chain reaction (qPCR) analysis. DOC 
significantly reduced transcription of both MAM and icsA (Fig. 7C), which was consistent 
with the attachment and invasion data. 
 
Figure 7 
Deoxycholate negatively regulates MAM and icsA in Shigella sonnei. 
Attachment of S. sonnei strains either grown in LB or LB containing deoxycholate (+ DOC) to HeLa 
cells following a 15 min infection at an MOI of 30 was determined by Triton X‐100 lysis and plating 
(A). Invasion of HeLa cells was determined by gentamycin protection experiments following 2 h of 
infection at an MOI of 10, either following growth in LB or LB containing DOC (+ DOC), (B). All 
results in A, B are means ± standard deviation (n = 3). Significance of results compared with those for 
the wild‐type strain was determined using a t‐test: *P  < 0.05, **P  < 0.01, ***P  < 0.0001. (C) qPCR 
analysis of MAM and icsA transcription upon deoxycholate treatment. Data present mean values from 
triplicate cultures (n = 3) for each strain. 
 
Finally, the effect of DOC on S. sonnei virulence in vivo was investigated in both the guinea 
pig keratoconjunctivitis and moth larvae models. DOC treatment significantly delayed the 
onset of conjunctivitis and reduced disease severity in guinea pigs (Fig. S6A) and also 
significantly protected moth larvae from killing by wild‐type as well as all mutant strains 
of S. sonnei (Fig. S6B). 
 
Discussion 
MAM‐mediated attachment is required for translocation of 
TTSS substrates into host cells 
In this study, we have demonstrated that SSO1327 encodes a functional MAM, which is 
expressed on the bacterial surface (Fig. 1) and involved in bacterial attachment to host cells, a 
key step during molecular pathogenesis (Fig. 2). Furthermore, we show that this initial step is 
essential for the translocation of a first wave of effectors, including IpgD, into host cells, 
which facilitates subsequent invasion. It is known that Shigella  bacteria can be internalized 
15 min after contacting HeLa cell monolayers (Mounier et al., 1997). Thus, although the 
initial attachment via adhesins and TTSS‐mediated invasion of non‐phagocytic cells are two 
distinctive events they occur rapidly in a continuing fashion. The graphs presented in Fig. 2A 
and D for attachment are likely to be a total sum of large numbers of extracellular and small 
numbers of intracellular S. sonnei. For scope of this study, it was unnecessary to exhaustively 
analyze the contribution of each of these two populations of bacteria. Most importantly, we 
have demonstrated that the deletion of MAM causes a decrease in initial cell‐associated 
bacteria, which has a knock‐on effect on invasion as shown in Fig. 2B. We further show that 
decreased adherence leads to inefficient translocation of early TTSS effectors from 
extracellular bacteria into the host cells cytoplasm, which implies strongly that both the 
decrease in attachment as well as the impairment of effector translocation play a role in the 
observed invasion deficiency. Like its ortholog from the sea‐foodborne 
pathogen V. parahaemolyticus, S. sonnei MAM specifically binds to fibronectin and 
phosphatidic acids (Fig. 2D). Most strikingly, failure to adhere to the host cell surface, either 
by deletion of the MAMgene or by competitive inhibition of MAM‐mediated binding using 
MAM‐based, synthetic beads, leads to a significant reduction of cell invasion and host 
protection in a moth larvae infection model (Figs 2 and 4). Deletion of MAM does not cause a 
secretion defect, as in the absence of MAM both IpaB and IpaC were still produced and 
secreted in response to the environmental cue, Congo red (Fig. 3A). This suggests that MAM 
does not directly impact on the function of TTSS. Conversely, TTSS function is not needed 
to achieve MAM‐mediated binding, as was previously shown 
in V. parahaemolyticus (Krachler and Orth, 2011; Krachler et al., 2011). Thus, we conclude 
that in contrast to IcsA, MAM and TTSS are mutually independent. However, bacteria fail to 
inject effector proteins into host cells, when MAM‐mediated attachment is abrogated by 
MAM gene deletion (Fig. 3). This finding suggests the following as a likely scenario: MAM‐
mediated intimate attachment brings the bacteria within close proximity of the cell 
membrane, allowing TTSS to engage with the cells’ membrane for activation. It is known 
that Shigella TTSS activation requires the formation of a translocon on the host cell 
membrane (Veenendaal et al., 2007). This event can only occur when Shigella  is within close 
proximity of the host cell surface. MAM is relatively small compared with other known 
adhesion molecules, such as flagella and pili (Jaglic et al., 2014). Therefore, intimate 
adherence by MAM may be required to bring Shigella  within close enough proximity to the 
host cell surface to allow TTSS translocon formation on the host cell membrane. It is known 
that Shigella  TTSS is also responsible for bacterial escape from the phagocytic vacuoles into 
the cell cytosol and cell‐to‐cell spread (High et al., 1992; Page et al., 1999). 
Whether ShigellaMAM plays a part in these events as well as in translocation of late effectors 
during intracellular growth requires further investigations. 
Recently, another surface protein, IcsA, has been described to mediate attachment 
of S. flexneri to the host cell surface, in addition to its role in actin based motility inside the 
host cells (Brotcke Zumsteg et al., 2014). In S. sonnei, IcsA's role is not redundant with 
MAM so both adhesins may be required during different stages of the infection process. 
In S. flexneri, IcsA‐mediated attachment depends on TTSS activity and, similar to TTSS 
function, is activated by bile salts, which leads to IcsA adopting an altered, protease resistant 
and attachment competent conformation (Brotcke Zumsteg et al., 2014). In S. sonnei, we also 
found IcsA to be necessary for adhesion and invasion (Fig. 2), but DOC caused a reduction in 
attachment and invasion by the wild‐type as well as the mutant strains (Fig. 7A and B). qPCR 
analysis confirmed that DOC caused significant reduction of MAM and IcsA transcription 
(Fig. 7C). The attenuation of virulence by DOC was further confirmed by Sereny test and in 
our newly established moth larvae model (Fig. S6A and S6B). The differential effect of DOC 
to S. flexneri and S. sonnei may explain why S. sonnei is less virulent and requires a much 
higher infectious dose to cause disease (DuPont et al., 1989). 
As noted earlier, the MAM gene in S. flexneri strain 301 (Sf1391) is a pseudogene because of 
an in frame stop codon (Yang et al., 2005). Thus, S. flexneri may have evolved different 
regulatory mechanisms to coordinate IcsA‐mediated attachment and TTSS. According to 
available genome sequences, a number of S. flexneri strains have the same in‐frame stop 
codon; they are Shi06HN006, 2003036, 2002017, 8401, and 2457T. We have also confirmed 
by PCR‐sequencing that strain M90T, used by (Brotcke Zumsteg et al., 2014) has the same 
mutation (data not shown). On the other hand, three S. flexneri genomes appear to have intact 
MAMs; AFGY01000021.1, AKMV010000023.1, and AKMY01000025.1. The significance 
of IcsA attachment in these strains with intact MAM genes remains to be investigated. 
Investigations to compare S. flexneri strains with and without intact MAM genes would help 
us gain a more detailed understanding of the regulation of attachment and cell invasion by 
DOC. 
Brotcke Zumsteg et al. (2014) also observed IcsA‐independent attachment. Although the 
molecular basis for IcsA‐independent attachment is unknown, MAM is unlikely to be 
involved as it is heavily truncated in this strain. Many genes involved in adherence are all lost 
in representatives of four groups of Shigella  strains, due to genome reduction, including 
fimbriae, pili and flagella (Yang et al., 2005). At the time of genome annotation MAM was 
not recognized. But, an intact orthologue of YadA from Yersinia pestis was noted in the 
genome of S. sonnei strain Ss046. The YadA orthologs in the other three classes 
of Shigella  all possess significant truncations at the C‐termini (Yang et al., 2005). YadA 
mediates effective attachment of Y. pestis to host cells and improves the delivery of the TTSS 
effector protein YopE (Rosqvist et al., 1990). Whether the truncated YadA is functional and 
responsible for the observed IcsA‐independent attachment in S. flexneri remains to be 
investigated. But, S. sonneiYadA is the prime suspect responsible for the residual attachment 
of the ΔMAMΔicsA double mutant observed (Fig. 2A). YadA mediates effective attachment 
of Y. pestis to host cells through binding to fibronectin and β1 integrin (Eitel and 
Dersch, 2002) and improves the delivery of the TTSS effector protein YopE 
(Rosqvist et al., 1990). Thus, the significance of the YadA ortholog in S. sonnei certainly 
deserves further investigation. 
G. mellonella larvae infection model 
Non‐human primate (NHP) rhesus monkeys (Macaca mulatta) are natural hosts of Shigella , 
with an infection phenotype that mimics human dysentery (Islam et al., 2014). This non‐
human primate model is however very costly. Therefore, other animal models such as the 
murine lung and rabbit ligated ileal loop models have been developed for defining some of 
the immune and inflammatory components of the disease (Philpott et al., 2000). Recently, the 
great moth, G. mellonella, has gained popularity as a model for assessing virulence and a 
number of pathogens have been studied using this model, including enteropathogenic E. coli 
(EPEC), Salmonella typhimurium and Listeria monocytogenes (Leuko and Raivio, 2012; 
Harding et al., 2013; Viegas et al., 2013). To our knowledge, this study is the first to report 
the use of this model for assessing virulence of Shigella . Wild-
type S. sonnei kills G. mellonella larvae in a dose‐dependent manner, and mutations in MAM 
and other virulence genes greatly increased larvae survival (e.g., Fig. 4). More importantly, 
our results have revealed that larvae killing by wild‐type S. sonnei is in part due to bacterial 
invasion of hemocytes, which eventually undergo apoptosis (Fig. 4 and Fig. S3). Deletion of 
the MAM gene or application of MAM‐based synthetic beads leads to reduced invasion of 
hemocytes and apoptosis (Fig. 5). Hemocytes possess characteristics of vertebrate 
macrophages (Harding et al., 2012). Induction of apoptosis in hemocytes is consistent with 
induction of apoptosis in human macrophages, due to activation of caspase I by secreted IpaB 
(Chen et al., 1996). Homologs to human caspases have been identified in G. mellonella and 
are involved in tissue remodelling during metamorphosis (Khoa et al., 2012). However, their 
characterization has been limited by the absence of a whole genome sequence and little is 
known about their role during infection. 
The results we obtained in the Galleria  larvae model were consistent with those obtained 
using the well‐established guinea pig keratoconjunctivitis model. Wild‐type S. sonnei induced 
full kertatoconjunctivitis within 3 days, whereas the MAM mutant failed to produce visible 
signs of the disease (Fig. 6). Our unpublished data show that several other mutations in well‐
defined virulence genes, including mxiD, ipaB and dsbA, also resulted in decreased mortality 
in the Galleria  larvae, consistent with these strains’ inability to cause conjunctivitis in the 
Sereny test. Taken together, these data indicate Galleria  larvae are a suitable initial model for 
studying Shigella  virulence and encourage its use for future studies. Our study along with 
others, also calls strongly for sequencing the genome of G. mellonella. 
Potential of MAM deletion strains as a new strategy for vaccine 
development 
Deletion of icsA attenuates Shigella  virulence in the Sereny test (Brotcke 
Zumsteg et al., 2014). This has been the basis of development of live attenuated vaccines, 
some of which are currently undergoing clinical trials (Rahman et al., 2011; 
Camacho et al., 2013). Although some of these candidates have shown promising results, 
their efficacy especially in endemic regions has proven insufficient (WHO, 2006). Our results 
show that a S. sonnei MAM deletion strain leads to attenuation of virulence in the guinea pig 
eye infection, but still elicited strong immune responses (Fig. 6). Thus, deletion of MAM may 
be an alternative approach in engineering future live attenuated vaccines for S. sonnei. 
The potential of using MAM as a target for therapy or 
vaccination 
The use of MAM‐based synthetic beads as an adhesion inhibitor has shown potential in the 
prevention of a number of bacterial infections, in particular in treating Pseudomonas 
infection of burns and wounds (Krachler et al., 2012a,b). Our results show clearly that 
applying MAM‐coupled polymer beads can reduce S. sonnei invasion of cultured host cells 
and protect Galleria  larvae from S. sonnei infection (Fig. 5). These data call for further 
investigations into the potential of MAM‐based adhesion inhibitors for therapy and 
vaccination. One uncertainty is whether a sufficient amount of beads could reach the 
intestinal tract following oral dosing. Dosing is easily controlled following topical application 
of beads to skin. However, it is hard to estimate how much inhibitor would be required via 
oral administration to ensure a sufficiently high concentration at the site of Shigella  infection, 
the rectocolon. In this regard, expression of MAM on the surface of probiotic bacteria such 
as Lactobacillus might be more practical. Shigella  infection elicits antibodies against invasion 
plasmid antigens (Ipa proteins) which does not offer protection. Shigella  infection or 
vaccination also elicit serotype‐specific antibodies that offer limited protection, which is not 
long lasting (Camacho et al., 2013). MAM is anticipated to induce a strong antibody response 
and again expression of MAM in probiotic bacteria may offer an alternative for protection 
against infection by all Shigella  strains with functional MAM. Taken together, the present 
study has uncovered a novel adhesin contributing to S. sonnei pathogenesis. Because of its 
essential role during infection and its ability to trigger a strong immune 
response, ShigellaMAM may offer future therapeutic potential in the prevention and 
treatment of shigellosis. 
Experimental procedures 
Bacterial strains and growth conditions 
The bacterial wild‐type strain used in this study was Shigella sonnei strain 20071599 
(Xu et al., 2014) and mutants thereof. Bacteria were routinely grown on Congo red 
Trypticase soy agar (TSA) plates or in liquid LB at 37°C. For pMAM‐His, 0.2 mM IPTG was 
added to the media to induce protein expression. To obtain EGFP expressing bacteria, strains 
were transformed with pGEM‐T‐easy or pET28a containing EGFP. 100 ȝg ml−1 ampicillin or 
50 ȝg ml−1kanamycin was added for selection of plasmid containing strains. All primers and 
strains used in this study are listed in Tables S1 and S2. 
Construction of S. sonnei deletion and complementation strains 
Gene deletions in the S. sonnei 20071599 background (Xu et al., 2014) were constructed 
using the phage Ȝ Red recombination system (Datsenko and Wanner, 2000). The plasmid, 
pKD46, which carries the red lambda recombinase genes, was transformed into strain 
20071599. The kanamycin resistance cassette flanked by the first and last 51 base pairs of 
MAM coding sequences was amplified by PCR using primers a, b (Table S1) and used to 
replace the wild‐type MAM gene via red lambda mediated homologs recombination 
(Fig. S1B). Plasmid, pCP20, was then introduced into the Kan‐resistant mutant strain, 
allowing a second homologs recombination to loop out the Kan‐cassette. The resultant strain, 
ΔMAM, harbored an in frame deletion with a scar of 102 base pairs 
(Fig. S1C). icsA and MAM icsA double knockout strains were constructed in the same way 
using primers g, h (Table S1). For complementation of the MAM deletion strain, the entire 
coding region of MAM SSO1327 was amplified with primers e and f (Table S1), which 
incorporated 6X histidine codons at the 3'‐end of the MAM coding sequence. The PCR 
product was cloned into pGEM‐T‐Easy (ampR), with the 5'‐end of the MAM coding 
sequence facing the lacZ promoter. The resultant clone was transformed into the 
ΔMAM mutant. For complementation of the icsA deletion strain, the promoter and entire 
coding sequence of SSOP143 icsA/virG gene was amplified with primers k and l (Table S1), 
which incorporated 5’ EcoRl and 3’ Sall restriction sites. The PCR product was cloned into 
pET28a (kanR). The resultant clone was transformed into the ΔicsA mutant. Plasmid, pMI, 
was constructed by cloning PCR‐amplified icsA gene with its promoter using primers k_Pst 
and l_Pst. The PCR product was cut with PstI and cloned into the PstI‐digested pMAM‐
6XHis clone. The resultant plasmid, pMI, was used to transform the ΔMAMΔicsAdouble 
mutant for complementation experiments. All steps of strain construction as well as 
complementation were confirmed by PCR and sequencing, using appropriate primers 
(Fig. S1C,D and Table S1). 
Cell fractionation and Western blotting to determine MAM 
localization 
For membrane preparation, bacterial cultures were grown overnight at 18°C, harvested by 
centrifugation (3500 rpm, 20 min, 4°C), washed once with PBS and resuspended in fresh lysis 
buffer TE (20 mM Tris, 10 mM EDTA, pH 8.0). Cells were sonicated for 12 cycles (30 s on, 
30 s off). Samples were first centrifuged at 15,000 × g for 45 min at 4°C to separate the 
supernatant. The supernatant fraction was then ultracentrifuged (60,000 × g, 1 h at 4°C). The 
pellets were subjected to phase separation to obtain the membrane fraction. Pellets were 
resuspended in 200 ȝl of 10 mM Tris‐HCI, pH 7.4, 150 mM NaCl, and 1% Triton X‐114 at 
0°C. For membrane protein separation, a cushion (300 ȝl) of 10 mM Tris HCl, pH 7.4, 
150 mM NaCl, 6% (w/v) sucrose, and 0.06% Triton X‐114 was placed first in 1.5 ml 
microfuge tube and then the protein sample was then overlaid. The tube was incubated at 
30°C for 3 min before centrifugation for 3 min at 300 × g. After centrifugation, the detergent 
phase was clearly separated at the bottom of the tube as an oily droplet, while the aqueous 
phase was on the top. The aqueous layer was removed and received 0.5% fresh Triton X‐114, 
the surfactant dissolution happened at 0°C and then overlaid on the sucrose cushion used 
before, incubated at 30°C for 3 min before centrifugation (Bordier C 1981). Finally, the oily 
droplets of detergent that assumed to have the amphiphilic integral membrane protein were 
analyzed by SDS‐PAGE and Western blot. 
OmpA was detected using the polyclonal antibody orb6940 (anti‐OmpA), followed by 
incubation with Alexa Fluor 680 F(ab)2 fragment of goat anti‐rabbit immunoglobulin G 
(IgG). MAM‐His was detected using the 6X‐His epitope Tag antibody (His‐H8), followed by 
incubation with anti‐mouse Alexa 680. Membranes were then viewed and imaged using a 
multi wavelength scanner at 700 nm. 
Analysis of MAM localization by immunostaining 
All strains ΔdsbA, ΔMAM, ΔMAM/pMAM‐His, and ΔdsbA/pdsbA‐His, were transformed with 
pET28a containing EGFP. Bacteria were grown in LB to mid‐log phase, and collected by 
centrifugation and washed once with PBS. Bacterial suspensions were then spotted on glass 
slides, left to dry, fixed by 4% paraformaldehyde for 10 min and then washed with PBS. 
Slides were treated with or without 0.1% Triton‐X100 in PBS, and then washed with PBS, 
and blocked for 30 min with 5% BSA in PBS. Primary staining was done on both sets using 
6X‐His epitope tag antibody (His‐H8) (1μ10 dilution in PBS) at RT for 30 min. Secondary 
staining was done using TRITC‐conjugated goat anti‐mouse antibody at RT for 30 min. 
Stained samples were analyzed by imaging on a Nikon Eclipse Ti fluorescence microscope 
(Nikon UK Ltd) and images were prepared using Image J (open 
source, http://imagej.nih.gov/ij/) and Corel Draw X5 (Nikon, Japan) (Corel Corporation, 
Ottawa, Canada). 
Adherence and invasion assays on cultured cells 
HEK293 and HeLa cells were routinely cultured at 37°C and under 5% CO2 in Dulbecco's 
modified eagle medium (DMEM) containing 10% heat‐inactivated fetal bovine serum, 
110 mg L−1 sodium pyruvate, 10 ml L−1 of 100× non‐essential amino acids, 100 
units ml−1penicillin and 20 ȝg ml−1 streptomycin. For adherence assays, bacteria were adjusted 
to an MOI of 30 in DMEM without supplements and added to host cells. Plates were 
centrifuged (1000 × g, 22°C, 5 min) prior to incubation for 15 min at 37°C. Following 
infection, cells were washed thoroughly with PBS (at least three times), and lysed by addition 
of 0.1% Triton X‐100 for 10 min. Lysates were serially diluted, plated on LB plates, 
incubated at 37°C overnight and colonies enumerated the next day. For PA depletion 
experiments, 50 ȝg ml−1PLC was added to tissue culture cells for 15 min prior to infection, as 
previously described (Lim et al., 2014). Fibronectin‐dependency was also tested as previously 
described (Krachler et al., 2012b), and bacterial cells were pre‐incubated with fibronectin 
from human plasma (200 ȝg ml−1 in PBS) for 30 min prior to infection. For invasion assays, 
cells were infected with MOI of 10; bacteria were added to cells and centrifuged (2000 rpm, 
22°C, 10 min), and incubated for 40 min. Following this, cells were washed with PBS prior to 
addition of 1 ml well−1 of DMEM containing 50 ȝg ml−1 gentamycin. The plate was then 
incubated for a further 2 h, cells washed three times with PBS, lysed and colony forming 
units determined using dilution plating, as described earlier. When testing the effect of MAM 
beads on invasion, host cells were treated with 5 ȝM MAM beads or control (GST‐coupled) 
beads for 30 min prior to invasion assays. Technical details of bead synthesis and molar ratio 
calculation have been described previously (Krachler and Orth, 2013, Stones et al., 2015). 
Analysis of TTSS effector production and secretion by Western 
blotting 
Colonies were picked from Congo red plates, and bacteria were grown in TSB to mid‐log 
phase. Cells were pelleted, washed with sterile PBS, resuspended in fresh PBS containing 
0.01% Congo red and incubated at 37°C for 30 min. When MAM and control beads were 
tested for their ability to interfere with TTSS, they were added at a final concentration of 
10 ȝM prior to the 30 min incubation. Cells were then centrifuged to separate samples into 
pellet fraction (to give total lysates reflecting protein production) and supernatants (to check 
for protein secretion). Pellets were washed once with PBS and boiled in sample buffer. 
Supernatants were used to precipitate proteins by precipitation with 10% TCA, as described 
previously (Yu et al., 2000). Following TCA addition, samples were incubated on ice for 
20 min prior to centrifugation to pellet proteins (14,000 rpm, 4°C, 20 min). Protein pellets 
were washed in 70% ethanol, dried, resuspended in SDS‐PAGE sample buffer and boiled for 
5 min. Samples were separated by SDS‐PAGE and IpaB and IpaC were detected by Western 
blotting using the monoclonal antibodies H16 (anti‐IpaB) and J22 (anti‐IpaC), respectively 
(Yu et al., 2000) followed by Alexa Fluor 680 goat anti‐mouse IgG and membranes were 
imaged on a multi wavelength scanner at 700 nm. 
Analysis of TTSS effector translocation by Förster resonance 
energy transfer 
In order to use red lambda system to create an ipgD‐TEM fusion (ipgD encodes a TTSS 
substrate and TEM encode β‐lactamase), we modified Plasmid pkD46 for kanamycin 
resistance instead of ampicillin resistance. By using inverse PCR the whole pkD46 
except blawas amplified using primers w and x (Table S1). The purified inverse PCR product 
as well as Kan‐cassette PCR product using pkD4 plasmid as template with primers u and v 
(Table S1), were digested using BglII restriction enzyme, then ligated and electroporated into 
DH5α. Colonies were selected on Kan/LB agar and the pKD46/pKD4 plasmid was extracted 
and verified for the right direction using XhoI and HindIII enzymes. The new pKD46/pKD4 
plasmid was introduced into both wild type and ΔMAM. The TEM gene was introduced to 
these two strains using primers s and t (Table S1), which resulted in an ipgD‐TEM in frame 
fusion. The empty pGEM‐T‐Easy (ampR) plasmid was transformed into wild type 
and ΔMAM to serve as negative controls. The constructed strains both possessed β‐lactamase 
activity and compared with negative controls (wild‐type strain), by use of nitrocefin discs 
according to the manufacturer's protocol (Oxoid, Hampshire, UK). Briefly, pure colonies of 
all strains were picked, suspended in PBS and applied directly to the discs and discs were 
incubated at 22°C for 30 min. Positive reaction was identified by red colored discs (Fig. S2). 
For FRET assays, 6X CCF4‐AM substrate loading solution was prepared, 106 cells of 
HEK2λ3 cells were prepared in 100 ȝl of EM buffer (120 mM NaCl, 7 mM KCl, 1.8 mM 
CaCl2, 0.8 mM MgCl2, 5 mM glucose) (Nothelfer et al., 2011). 20 ȝl of 6X CCF4‐AM were 
added to each tube of 100 ȝl of the cells and incubated in the dark at 22°C for 1 h. 
Fluorescence Resonance Energy Transfer (FRET) reporter strains were added to HEK293 
cells at an MOI of 100 in DMEM and centrifuged (300 g, 10 min, 22°C) prior to incubation at 
37°C for 50 min (Nothelfer et al., 2011). Cells were washed once with PBS, and the infection 
was stopped by adding EM buffer containing 50 ȝg ml−1 gentamycin. Cells were fixed with 
4% paraformaldehyde and mounted on glass slides for FRET imaging, using a Nikon A1R 
confocal fluorescence microscope. Ratiometric analysis was done using Image J. 
Alternatively; cells were subjected to analysis by flow cytometry (excitation 355 nm, and 
emission 457 nm for coumarin and emission 52λ nm for fluorescein). 
G. mellonella larvae infection model 
Bacterial strains were grown to mid‐log phase in LB to prepare stocks for infections. For each 
experimental condition, 10 healthy 2‐ to 3‐day‐old larvae of approximately equal weight were 
infected with S. sonnei strains by injection of 10 ȝl total volume into the front, right proleg. 
The control group received the same volume of sterile PBS buffer instead. Two infectious 
doses (105 CFU and 106 CFU) were tested. As a dose of 106 CFU S. sonnei wild‐type strain 
caused mortality within one day, the lower dose was used for subsequent experiments; 
exceptions are stated in the figure legend. For MAM bead protection experiments, larvae 
were co‐injected with 10 ȝl total volume containing a mixture of either 105 CFU or 
106 CFU S. sonnei wild‐type bacteria and 6–25 ȝM MAM or GST (control) beads. 
Preparation of MAM beads has been described elsewhere (Lim et al., 2014). To study the 
effects of DOC treatment on infection, larvae were challenged with S. sonnei strains grown 
overnight with or without DOC (2.5 mM). Following infection, larvae were incubated at 
37°C and larval survival was scored daily, for five days. Larvae were scored as dead when 
they no longer responded to touch. Survival data were analyzed using the Kaplan–Meier 
estimator. Survival curves were compared using the Mantel–Cox log–rank test and 
differences in the mortality of larvae infected with wild‐type and ΔMAM strains were 
significantly different (P  < 0.0001). 
G. mellonella hemolymph processing for flow cytometry and 
microscopy 
Following 4 h of infection, hemolymph of 10 larvae per experimental condition was collected 
by making an incision between the two segments nearest the larvae tail to avoid gut 
disruption. Hemolymph was collected in 0.5 ml of sterile PBS and processed within 10 min to 
prevent clotting (Harding et al., 2013). For imaging, hemolymph was transferred to a glass 
coverslip in a 24‐well plate; 0.5 ml of PBS was added and mixed well. The plate was then 
centrifuged at 2000 rpm for 10 min at room temperature using an aerosol‐tight centrifuge 
plate holder. The supernatant was carefully removed and cells were washed with PBS. Cells 
were fixed in 4% (v/v) paraformaldehyde in PBS for 10 min. 0.5 ml of 15 mM NH4Cl in PBS 
was used to quench residual paraformaldehyde and the plate was incubated at RT for 15 min. 
Afterwards, cells were permeabilized for 5 min at RT using 0.5 ml of 0.1% Triton X‐100 in 
PBS. Blocking was done for 1 h using 2% (w/v) BSA in PBS, and then cells were stained 
with Alexa Flour 548‐phalloidin and Hoechst. Samples were mounted and cured overnight 
prior to imaging. For flow cytometry, hemolymph was centrifuged at 2000 rpm for 10 min at 
RT, and hemocytes were resuspended in 1 ml PBS containing 4% (v/v) paraformaldehyde in 
PBS for fixation. Cells were vigorously mixed and then were used for flow cytometry. For 
analysis, lasers emitting at 488 nm were used for detection of EGFP expressing bacteria. Data 
acquisition and analysis was performed using Kaluza™ software (Beckman Coulter, Brea, 
USA). 
qPCR analysis of icsA and MAM transcription 
Wild‐type S. sonnei strain was grown in the presence or absence of 2.5 mM DOC overnight 
in L‐broth with shaking (200 rpm). RNA was isolated using a Total RNA kit (Bioline). The 
house‐keeping gene, cycG, was used as an internal control. Primers y,z; y1,z1 and y2,z2 
(Table S1) were used to prepare cDNA for icsA, MAM and cycG genes, respectively. To 
establish standard curves for each gene, a serial dilution (from 100 to 108 molecules ȝl−1) of 
bacterial genomic DNA was used for PCR using SYBR‐Green QRT‐PCR kit on Rotor Gene 
6000 (Qiagen, Life Sciences and Technology UK). Changes in gene expression between 
untreated and DOC‐treated cultures were calculated using the 2−ΔΔct method and proprietary 
software in the Rotor Gene instrument (version 1.7.34). Triplicate RNA samples from 
triplicate cultures (n = 3) were used to prepare cDNAs, which were quantified by the same 
PCR procedure. The amplification curves of MAM and icsA were normalized with that 
of cycG, and quantification was calculated using the standard curves. The levels of transcripts 
from bacteria grown in the absence of DOC were set as calibrator and levels of transcripts 
from bacteria grown in the presence of DOC were expressed as log2−ΔΔct. 
Guinea pig keratoconjunctivitis model (Sereny test) 
Experimental protocols involving guinea pigs were performed with approval of Xi'an Jiao 
Tong University ethics committee. Guinea pigs 6–8 weeks old, weighing 200–300 g, were 
infected with 5 × 108 CFU per eye of S. sonnei wild‐type or ΔMAM strains, as previously 
described (Xu et al., 2014). For testing DOC regulation, wild‐type S. sonnei was grown 
overnight in the presence or absence of 2.5 mM DOC. Development of keratoconjunctivitis 
was monitored and scored daily up to 14 days. 
Immunization experiments 
Guinea pigs (n = 3) were infected with 5 × 108 of ΔMAM strain per eye at days 1, 14 and 28. 
On day 31, wild‐type S. sonnei (5 × 108 CFU per eye) were used to challenge the animals. 
Animals were observed daily for development of keratocunjunctivitis. A second group of 
guinea pigs (n = 3) were immunized with ΔMAM strain on days 1, 14, 28, 32 and 48. On day 
51, animals of the immunization group as well as those challenged with wild‐
type S. sonnei were sacrificed. Spleen lymphocytes were isolated for detecting specific ASCs 
against S. sonnei by ELISPOT. All procedures were described previously (Xu et al., 2014). 
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